Chad Orevillo

Chad Orevillo, MPH is co-founder and Executive Vice President and Head of Operations of Longboard Pharmaceuticals, Inc. Mr. Orevillo has 30 years of industry experience in pharmaceutical clinical development and operations and leading project teams from early to late phase development. He has a wide breadth of experience spanning from start-up biotech to large global pharma companies including Merck, Pharmacia, Pfizer, Novartis, Pearl Therapeutics, Astrazeneca and Arena Pharmaceuticals. Mr. Orevillo has an M.P.H. from Tulane University and B.S. in Biology from William Paterson University and is a veteran of the US Marine Corps.